Wordt geladen...
Tricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease
BACKGROUND: Tricyclic antidepressants (TCAs) have efficacy in treating irritable bowel syndrome (IBS). Some clinicians use TCAs to treat residual symptoms in inflammatory bowel disease (IBD) patients already on decisive IBD therapy or with quiescent inflammation, although this strategy has not been...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4111227/ https://ncbi.nlm.nih.gov/pubmed/24406434 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000000049 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|